MetaCap

Azora Therapeutics Insider Trades

NASDAQ: AZRHealth CareBiotechnology: Pharmaceutical PreparationsUSD

3.85-0.02 (-0.52%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
5 · $106.33K
Sales
0 · $0
Shares bought / sold
39.99K / 0
Net activity
Net buying $106,329

Azora Therapeutics insider activity

Over the last 12 months, Azora Therapeutics insiders reported 19 transactions on SEC Form 4: 5 open-market purchases and 0 sales. Insiders bought $106,329 and sold $0 worth of stock, for net insider buying of $106,329. The most recent filing shows Davidson Matt (President and CEO) reporting a transaction in 524,954 shares on Nov 2, 2026.

Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put AZR's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

AZR insider transactions

Azora Therapeutics insider transactions
DateInsiderTypeSharesValueFiling
Nov 2, 2026Saiki JulieChief Strategy OfficerConversion626,252—Form 4
Nov 2, 2026Davidson MattPresident and CEOConversion101,298—Form 4
Nov 2, 2026Davidson MattPresident and CEOConversion524,954—Form 4
Oct 28, 2026Davidson MattPresident and CEOAward232,417—Form 4
Jul 16, 2026Coastlands Capital LP10% OwnerBuy1,233$3.39KForm 4
Jul 14, 2026Coastlands Capital LP10% OwnerBuy2,000$5.30KForm 4
Jul 10, 2026Coastlands Capital LP10% OwnerBuy1,700$4.59KForm 4
Jul 9, 2026Coastlands Capital LP10% OwnerBuy10,053$28.05KForm 4
Jun 29, 2026Coastlands Capital LP10% OwnerBuy25,000$65.00KForm 4
Jun 12, 2026Davidson MattChief Development OfficerAward232,417—Form 4
Jun 11, 2026Davidson MattChief Development OfficerAward101—Form 4
Jun 11, 2026Davidson MattChief Development OfficerAward1,822—Form 4
Jun 11, 2026Davidson MattChief Development OfficerAward3,427—Form 4
Jun 11, 2026Davidson MattChief Development OfficerAward61,647—Form 4
Apr 7, 2026Shah VinayChief Financial OfficerAward17,325—Form 4
Apr 7, 2026Schuyler KevinDirectorAward9,185—Form 4
Apr 7, 2026Claiborne Cary JChief Executive OfficerAward37,985—Form 4
Apr 7, 2026Gilliland Robertson H.DirectorAward9,185—Form 4
Apr 7, 2026Goodman TonyChief Operating OfficerAward26,510—Form 4
Sep 29, 2023Schuyler KevinDirectorBuy700$1.92KForm 4
May 23, 2023Claiborne Cary JChief Executive OfficerAward420,000—Form 4
May 23, 2023Stilley William B. IIIDirectorAward240,800—Form 4
May 23, 2023Truluck JosephChief Financial OfficerAward157,500—Form 4
Dec 30, 2022Stilley William B. IIIDirectorDisposition166,667—Form 4
Sep 20, 2022Claiborne Cary JChief Executive OfficerAward75,000$31.52KForm 4
Sep 19, 2022Claiborne Cary JChief Executive OfficerAward25,000$10.73KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related